Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-19-000428

Director sold 8,347 shares at $219.33 ($1,830,731)

  • Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Nusse Roeland · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-11-25 Exercise or conversion : show line 1 in the form +10,000 $60.46 $604,600 15,721 D
2019-11-25 Exercise or conversion : show line 2 in the form +5,000 $61.46 $307,300 20,721 D
2019-11-25 Sale : show line 3 in the form −8,347 $219.33 $1,830,731 12,374 D
Open-market sales · 8,347 sh · avg $219.33 · $1,830,731

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-11-25 Exercise or conversion : show line 4 in the form Stock Option (right to buy) −10,000 0 D
2019-11-25 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −5,000 0 D
Loading xslF345X03/edgar.xml…